GM04536
Amniotic fluid-derived cell line from Amniotic fluid
Description:
INVERTED CHROMOSOME
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Chromosome Abnormalities |
Biopsy Source
|
Amniotic fluid
|
Cell Type
|
Amniotic fluid-derived cell line
|
Transformant
|
Untransformed
|
Sample Source
|
Amniotic fluid-derived cell line from Amniotic fluid
|
Race
|
More than one race
|
Ethnicity
|
BLACK/CAUCASIAN
|
Relation to Proband
|
proband
|
Confirmation
|
Karyotypic analysis after cell line submission to CCR
|
ISCN
|
46,XX,inv(2)(pter>p21::q14.2>p21::q14.2> qter),inv(9)(pter>p11::q13>p11::q13>qter)
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
7 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Chromosome Analysis |
|
Cytogenetics |
Chromosome 2: INVERSION Breakpoint 2p21 inv(2)2p21 |
|
Chromosome 2: INVERSION Breakpoint 2q21 inv(2)2q21 |
|
Chromosome 9: INVERSION Breakpoint 9p11 inv(9)9p11 |
|
Chromosome 9: INVERSION Breakpoint 9q13 inv(9)9q13 |
Remarks |
46,XX,inv(2)(pter>p21::q21>p21::q21> qter),inv(9)(pter>p11::q13>p11::q13> qter); balanced; Black/Caucasian; phenotypically normal |
Passage Frozen |
7 |
Split Ratio |
1:6 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Amniotic Fluid Culture Medium |
Serum |
none |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|